Stock Track | Agios Pharmaceuticals Soars 5% Despite Concerns Over Earnings Quality

Stock Track11-08

Shares of Agios Pharmaceuticals Inc. (AGIO) rose 5% on Wednesday, even as a financial analysis raised concerns about the quality of the pharmaceutical company's recent earnings report. The stock surge came despite a warning from Simply Wall St. that Agios' profit was boosted by unusual items and did not match its free cash flow.

According to the analysis, Agios had an accrual ratio of 2.33 for the year to September 2024, indicating that its profit significantly exceeded its free cash flow. The company reported a profit of $674.3 million but had negative free cash flow of $330 million during that period, suggesting that its earnings may be overstating its actual financial performance.

Additionally, the analysis noted that Agios' profit was boosted by unusual items worth $1.1 billion in the last twelve months, which can make its statutory profits appear stronger than they really are. While unusual items can sometimes be one-off occurrences, their significant contribution to Agios' earnings raised concerns about the quality and sustainability of the company's profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142227548?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 04:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142227548","market":"hk","top_or_hot":-1,"title":"Stock Track | Agios Pharmaceuticals Soars 5% Despite Concerns Over Earnings Quality","media":"Stock Track","content":"<p>Shares of Agios Pharmaceuticals Inc. (AGIO) rose 5% on Wednesday, even as a financial analysis raised concerns about the quality of the pharmaceutical company's recent earnings report. The stock surge came despite a warning from Simply Wall St. that Agios' profit was boosted by unusual items and did not match its free cash flow.</p>\n<p>According to the analysis, Agios had an accrual ratio of 2.33 for the year to September 2024, indicating that its profit significantly exceeded its free cash flow. The company reported a profit of $674.3 million but had negative free cash flow of $330 million during that period, suggesting that its earnings may be overstating its actual financial performance.</p>\n<p>Additionally, the analysis noted that Agios' profit was boosted by unusual items worth $1.1 billion in the last twelve months, which can make its statutory profits appear stronger than they really are. While unusual items can sometimes be one-off occurrences, their significant contribution to Agios' earnings raised concerns about the quality and sustainability of the company's profitability.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Agios Pharmaceuticals Soars 5% Despite Concerns Over Earnings Quality</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Agios Pharmaceuticals Soars 5% Despite Concerns Over Earnings Quality\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-08 04:36 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Agios Pharmaceuticals Inc. (AGIO) rose 5% on Wednesday, even as a financial analysis raised concerns about the quality of the pharmaceutical company's recent earnings report. The stock surge...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGIO","symbol_name":"Agios Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1142227548","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142227548","pubTimestamp":1731011793,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Agios Pharmaceuticals Inc.  rose 5% on Wednesday, even as a financial analysis raised concerns about the quality of the pharmaceutical company's recent earnings report. The stock surge came despite a warning from Simply Wall St. that Agios' profit was boosted by unusual items and did not match its free cash flow.According to the analysis, Agios had an accrual ratio of 2.33 for the year to September 2024, indicating that its profit significantly exceeded its free cash flow. The company ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AGIO":"Agios Pharmaceuticals, Inc."},"translate_title":"尽管盈利质量令人担忧，Agios Pharmaceuticals股价仍飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGIO":1},"content_text":"Shares of Agios Pharmaceuticals Inc. (AGIO) rose 5% on Wednesday, even as a financial analysis raised concerns about the quality of the pharmaceutical company's recent earnings report. The stock surge came despite a warning from Simply Wall St. that Agios' profit was boosted by unusual items and did not match its free cash flow.\nAccording to the analysis, Agios had an accrual ratio of 2.33 for the year to September 2024, indicating that its profit significantly exceeded its free cash flow. The company reported a profit of $674.3 million but had negative free cash flow of $330 million during that period, suggesting that its earnings may be overstating its actual financial performance.\nAdditionally, the analysis noted that Agios' profit was boosted by unusual items worth $1.1 billion in the last twelve months, which can make its statutory profits appear stronger than they really are. While unusual items can sometimes be one-off occurrences, their significant contribution to Agios' earnings raised concerns about the quality and sustainability of the company's profitability.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142227548"}